Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 11 | 2021 | 57 | 2.030 |
Why?
|
| Catheter Ablation | 9 | 2021 | 21 | 1.240 |
Why?
|
| Atrial Appendage | 2 | 2018 | 13 | 0.710 |
Why?
|
| Heart Transplantation | 1 | 2018 | 14 | 0.570 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 30 | 0.560 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2020 | 4 | 0.510 |
Why?
|
| Pulmonary Veins | 3 | 2020 | 6 | 0.480 |
Why?
|
| Treatment Outcome | 9 | 2021 | 1478 | 0.360 |
Why?
|
| Pacemaker, Artificial | 2 | 2022 | 4 | 0.350 |
Why?
|
| Electric Injuries | 1 | 2011 | 1 | 0.350 |
Why?
|
| Spasm | 1 | 2011 | 1 | 0.350 |
Why?
|
| Intercostal Muscles | 1 | 2011 | 2 | 0.350 |
Why?
|
| Bundle of His | 2 | 2021 | 2 | 0.340 |
Why?
|
| Cryosurgery | 2 | 2020 | 12 | 0.320 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2018 | 19 | 0.290 |
Why?
|
| Humans | 18 | 2022 | 12240 | 0.270 |
Why?
|
| Male | 12 | 2021 | 6815 | 0.250 |
Why?
|
| Aged | 9 | 2021 | 4000 | 0.240 |
Why?
|
| Electric Countershock | 1 | 2005 | 6 | 0.230 |
Why?
|
| Registries | 3 | 2021 | 88 | 0.230 |
Why?
|
| Thrombosis | 2 | 2018 | 33 | 0.220 |
Why?
|
| Anticoagulants | 2 | 2018 | 42 | 0.190 |
Why?
|
| Retrospective Studies | 7 | 2021 | 1467 | 0.180 |
Why?
|
| Electrocoagulation | 1 | 2022 | 3 | 0.180 |
Why?
|
| Equipment Design | 2 | 2021 | 76 | 0.180 |
Why?
|
| Heart Rate | 2 | 2019 | 55 | 0.180 |
Why?
|
| Action Potentials | 2 | 2019 | 64 | 0.180 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2021 | 14 | 0.180 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2021 | 2 | 0.170 |
Why?
|
| Bradycardia | 1 | 2021 | 15 | 0.170 |
Why?
|
| Heart Ventricles | 1 | 2021 | 50 | 0.170 |
Why?
|
| Atrial Flutter | 2 | 2011 | 2 | 0.170 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 2 | 0.160 |
Why?
|
| Exercise Tolerance | 1 | 2020 | 16 | 0.160 |
Why?
|
| Time Factors | 5 | 2021 | 695 | 0.160 |
Why?
|
| Heparin Antagonists | 1 | 2019 | 1 | 0.150 |
Why?
|
| Protamines | 1 | 2019 | 1 | 0.150 |
Why?
|
| Hemostasis | 1 | 2019 | 7 | 0.150 |
Why?
|
| Heparin | 1 | 2019 | 12 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2019 | 30 | 0.150 |
Why?
|
| Suture Techniques | 1 | 2019 | 65 | 0.150 |
Why?
|
| Punctures | 1 | 2018 | 4 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 12 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 19 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2018 | 25 | 0.140 |
Why?
|
| Contrast Media | 1 | 2018 | 32 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2018 | 31 | 0.140 |
Why?
|
| Exercise | 1 | 2020 | 233 | 0.140 |
Why?
|
| Risk Assessment | 3 | 2020 | 295 | 0.130 |
Why?
|
| Adult | 5 | 2021 | 3557 | 0.130 |
Why?
|
| Female | 8 | 2021 | 6974 | 0.130 |
Why?
|
| Middle Aged | 7 | 2020 | 4043 | 0.120 |
Why?
|
| Risk Factors | 4 | 2020 | 1049 | 0.110 |
Why?
|
| Recurrence | 3 | 2020 | 126 | 0.100 |
Why?
|
| Stroke | 2 | 2011 | 117 | 0.090 |
Why?
|
| Heart Atria | 1 | 2011 | 13 | 0.090 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2011 | 7 | 0.090 |
Why?
|
| Stroke Volume | 2 | 2021 | 26 | 0.080 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2010 | 6 | 0.080 |
Why?
|
| Telemetry | 1 | 2010 | 5 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2010 | 4 | 0.080 |
Why?
|
| Coronary Occlusion | 1 | 2010 | 1 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2010 | 35 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 1 | 2009 | 13 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2009 | 19 | 0.080 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 8 | 0.060 |
Why?
|
| Warfarin | 1 | 2005 | 11 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 2152 | 0.050 |
Why?
|
| Thermography | 1 | 2021 | 3 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 33 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 43 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 2021 | 27 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 113 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 128 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 7 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 7 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 66 | 0.040 |
Why?
|
| Alcoholism | 1 | 2020 | 34 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2020 | 22 | 0.040 |
Why?
|
| Lasers | 1 | 2020 | 9 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 26 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2020 | 15 | 0.040 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 17 | 0.040 |
Why?
|
| Exercise Test | 1 | 2020 | 62 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 58 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 56 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 85 | 0.040 |
Why?
|
| Hemostatic Techniques | 1 | 2019 | 6 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 290 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 338 | 0.040 |
Why?
|
| Age Factors | 1 | 2020 | 350 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 156 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 324 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 817 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 863 | 0.030 |
Why?
|
| United States | 1 | 2019 | 989 | 0.030 |
Why?
|
| Animals | 1 | 2021 | 2092 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 252 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 28 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2010 | 30 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 2010 | 11 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 218 | 0.020 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 2 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2009 | 47 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 174 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 64 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2010 | 30 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 158 | 0.020 |
Why?
|
| Chicago | 1 | 2010 | 453 | 0.020 |
Why?
|
| Adolescent | 1 | 2009 | 989 | 0.020 |
Why?
|